Recent News
Johnson & Johnson expands project that aims to predict, prevent diseases
March 22, 2016 | Written By: Tribune news services | Source: ChicagoTribune Johnson & Johnson has ramped up its ambitious project to learn how to predict who will develop particular diseases and find therapies to prevent or stop the disease early, when it's most treatable. Since the health care giant announced its... More
Stopping Lung Cancer Before It Gets Going
March 7, 2016 | Written By: Upal Basu Roy, MPH, PhD | Source: LUNGevity “The LUNGevity award provided me the resources to study premalignant lung cells—a stage in which normal lung cells have changed, but not yet completely into cancer cells. This is an extremely important area of cancer research for... More
How RNA Editing May Promote Tumor Growth
Thursday, March 17 2016 | Source: BUSM A new study provides insight on the potential role played by RNA (ribonucleic acid) editing in cancer. The findings, which appear online in the journal Scientific Reports, may further our understanding of an emerging mechanism implicated in tumor initiation and progression, and may thus lead to... More
New test could sharply reduce risky, costly lung cancer biopsies
Press Release: May 18, 2015 | Written by Lenny Bernstein - The Washington Post When a suspicious lesion shows up in the lungs on a CT scan, the first thing your doctor wants to know is whether it's cancerous. A specialist will pass a long, thin bronchoscope into your airway in the hope of... More
Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier
Press: April 16, 2015 | Veracyte South San Francisco, Calif. --- April 16, 2015 --- Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta™ Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The... More
Behind the Vapor – Chasing the facts behind e-cigarette health risks
Press: October 20, 2014; written by Sara Rimer | BU Research With the public health community sharply divided over the potential benefit and harm of the popular device—and with conclusive scientific evidence in short supply—the World Health Organization (WHO) released a report in August 2014 that raised serious questions about the health impact... More
Researchers will study relation of environment to breast cancer
Press: October 16th 2014, written by Todd Feathers | Boston Globe Five eminent Boston researchers will officially join forces Thursday to tackle one of the most perplexing questions about breast cancer: Why do so many people with no family history of the disease get it? The researchers will examine whether common man-made... More
Veracyte to Acquire Allegro Diagnostics: Plans to Launch Lung Cancer Test
Press release: September 4th 2014 SOUTH SAN FRANCISCO, Calif., Sept. 4, 2014 /PRNewswire/ -- Veracyte, a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to acquire Allegro Diagnostics Corp. based in Maynard, Mass., for $21.0 million, comprised of $7.8 million in cash and $13.2 million in Veracyte... More
New way to determine cancer risk of chemicals found
Press Release from July 24th 2014 A new study has shown that it is possible to predict long-term cancer risk from a chemical exposure by measuring the short-term effects of that same exposure. The findings, which currently appear in the journal PLOS ONE, will make it possible to develop simpler and cheaper... More
BUSM Researchers Identify Molecule that Could Aid Lung Cancer Detection, Treatment
Press Release: From October 28th 2013 Written by Jenny C Leary Researchers at Boston University School of Medicine (BUSM) have discovered a molecule that could help lead to the non-invasive detection of lung cancer as well as its treatment. Using RNA sequencing, the team looked at airway epithelial cells and identified a... More